Development of a membrane-disruption assay using phospholipid vesicles as a proxy for the detection of cellular membrane degradation.

varespladib (A-002) - Anthera Pharma, Ophirex

http://www.ncbi.nlm.nih.gov/pubmed/38633504

Daniel Da Costa Pereira; Eric Wachtel; Freek J Vonk; Jeroen Kool; Julien Slagboom; Mátyás A Bittenbinder; Nicholas R Casewell; Paul Jennings

Apr 18, 2024